DE69637731D1 - Antimikrobielle kationische peptide und methoden zu ihrer identifizierung - Google Patents
Antimikrobielle kationische peptide und methoden zu ihrer identifizierungInfo
- Publication number
- DE69637731D1 DE69637731D1 DE69637731T DE69637731T DE69637731D1 DE 69637731 D1 DE69637731 D1 DE 69637731D1 DE 69637731 T DE69637731 T DE 69637731T DE 69637731 T DE69637731 T DE 69637731T DE 69637731 D1 DE69637731 D1 DE 69637731D1
- Authority
- DE
- Germany
- Prior art keywords
- sub
- entry
- row
- seq
- tryptophan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US268795P | 1995-08-23 | 1995-08-23 | |
PCT/IB1996/000996 WO1997008199A2 (en) | 1995-08-23 | 1996-08-23 | Antimicrobial cationic peptides and methods of screening for the same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69637731D1 true DE69637731D1 (de) | 2008-12-11 |
Family
ID=21701983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69637731T Expired - Lifetime DE69637731D1 (de) | 1995-08-23 | 1996-08-23 | Antimikrobielle kationische peptide und methoden zu ihrer identifizierung |
Country Status (10)
Country | Link |
---|---|
US (2) | US6191254B1 (de) |
EP (1) | EP0846128B1 (de) |
JP (1) | JP3860838B2 (de) |
AT (1) | ATE412668T1 (de) |
AU (1) | AU6940796A (de) |
CA (1) | CA2230160A1 (de) |
DE (1) | DE69637731D1 (de) |
ES (1) | ES2316154T3 (de) |
HK (1) | HK1011867A1 (de) |
WO (1) | WO1997008199A2 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503881B2 (en) | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
US6180604B1 (en) | 1996-08-21 | 2001-01-30 | Micrologix Biotech Inc. | Compositions and methods for treating infections using analogues of indolicidin |
EP1174439B1 (de) * | 1996-08-21 | 2008-10-08 | Migenix Inc. | Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen |
US6303575B1 (en) | 1998-05-12 | 2001-10-16 | The Regents Of The University Of California | Indolicidin analogs and methods of using same |
US6444645B1 (en) * | 1998-06-18 | 2002-09-03 | The Regents Of The University Of California | Crosslink-stabilized indolicidin analogs |
US6288212B1 (en) * | 1998-08-28 | 2001-09-11 | The University Of British Columbia | Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
BR9914922A (pt) * | 1998-10-30 | 2001-07-10 | Interlink Biotechnologies Llc | Métodos para reduzir a extensão de degradação de protease de uma proteìna aplicada a ou produzida por uma planta, para inibir o crescimento de um patógeno vegetal e para produzir uma planta, peptìdeo, molécula de ácido nucleico, segmento de ácido nucleico, construção de ácido nucleico, planta transgênica, semente, célula vegetal, e, composição para o uso na proteção de um peptìdeo, polipeptìdeo ou proteìna da degradação da protease. |
US6946261B1 (en) * | 1998-11-20 | 2005-09-20 | Migenix Inc. | Efficient methods for producing anti-microbial cationic peptides in host cells |
US6335318B1 (en) | 1999-05-10 | 2002-01-01 | The Regents Of The University Of California | Antimicrobial theta defensins and methods of using same |
US6497676B1 (en) | 2000-02-10 | 2002-12-24 | Baxter International | Method and apparatus for monitoring and controlling peritoneal dialysis therapy |
US6337317B1 (en) | 2000-06-27 | 2002-01-08 | The University Of British Columbia | Antimicrobial peptides and methods of use thereof |
US6835536B2 (en) | 2001-08-21 | 2004-12-28 | Micrologix Biotech Inc. | Antimicrobial cationic peptides and formulations thereof |
WO2003018619A2 (en) | 2001-08-24 | 2003-03-06 | Micrologix Biotech Inc. | Antimicrobial and anti-inflammatory peptides |
KR100438416B1 (ko) * | 2001-09-19 | 2004-07-02 | 학교법인조선대학교 | Ca-ma 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 + 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물 |
US7507787B2 (en) * | 2001-12-03 | 2009-03-24 | The University Of British Columbia | Effectors of innate immunity |
US20030125662A1 (en) * | 2002-01-03 | 2003-07-03 | Tuan Bui | Method and apparatus for providing medical treatment therapy based on calculated demand |
US20030219854A1 (en) * | 2002-03-21 | 2003-11-27 | Micrologix Biotech Inc. | Methods for producing modified anti-infective peptides |
WO2003091429A1 (fr) * | 2002-04-25 | 2003-11-06 | Toagosei Co.,Ltd. | Polypeptide microbicide et ses utilisations |
US7119070B2 (en) | 2002-04-30 | 2006-10-10 | The Regents Of The University Of California | Antimicrobial theta defensins, analogs thereof, and methods of use |
US7033769B2 (en) * | 2002-05-23 | 2006-04-25 | The United States Of America As Represented By The Secretary Of The Army | Method for discovering one or more peptides adapted for specific binding to a microorganism of interest |
US7238164B2 (en) * | 2002-07-19 | 2007-07-03 | Baxter International Inc. | Systems, methods and apparatuses for pumping cassette-based therapies |
WO2005019241A2 (en) * | 2003-08-18 | 2005-03-03 | E.I. Dupont De Nemours And Company | Cationic antimicrobial peptides and compositions thereof |
WO2005049819A1 (ja) * | 2003-10-29 | 2005-06-02 | Toagosei Co., Ltd. | 抗菌ペプチド及びその利用 |
US20050209563A1 (en) * | 2004-03-19 | 2005-09-22 | Peter Hopping | Cassette-based dialysis medical fluid therapy systems, apparatuses and methods |
JP4507080B2 (ja) * | 2004-07-30 | 2010-07-21 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
JP4730584B2 (ja) | 2004-12-06 | 2011-07-20 | 東亞合成株式会社 | 抗菌ペプチド及びその利用 |
US8252737B2 (en) * | 2004-12-15 | 2012-08-28 | The Regents Of The University Of Colorado | Antimicrobial peptides and methods of use |
US20090030179A1 (en) * | 2005-02-15 | 2009-01-29 | Toagosei Co., Ltd | Antimicrobial peptide and use thereof |
US7998115B2 (en) * | 2007-02-15 | 2011-08-16 | Baxter International Inc. | Dialysis system having optical flowrate detection |
US8558964B2 (en) | 2007-02-15 | 2013-10-15 | Baxter International Inc. | Dialysis system having display with electromagnetic compliance (“EMC”) seal |
US8870812B2 (en) * | 2007-02-15 | 2014-10-28 | Baxter International Inc. | Dialysis system having video display with ambient light adjustment |
US7731689B2 (en) | 2007-02-15 | 2010-06-08 | Baxter International Inc. | Dialysis system having inductive heating |
US8361023B2 (en) * | 2007-02-15 | 2013-01-29 | Baxter International Inc. | Dialysis system with efficient battery back-up |
ES2805225T3 (es) * | 2007-07-26 | 2021-02-11 | Revance Therapeutics Inc | Péptidos antimicrobianos y composiciones de los mismos |
WO2010042534A1 (en) * | 2008-10-06 | 2010-04-15 | The Regents Of The University Of Colorado, A Body Corporate | Peptides and methods of use |
GB0821616D0 (en) * | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
WO2010141760A2 (en) * | 2009-06-05 | 2010-12-09 | The Regents Of The University Of Colorado, A Body Corporate | Antimicrobial peptides |
US9134323B2 (en) | 2009-12-01 | 2015-09-15 | The Rockefeller University | Antibody that specifically binds to an epitope in the tureet region of a human Kir channel |
US11225655B2 (en) | 2010-04-16 | 2022-01-18 | Nuevolution A/S | Bi-functional complexes and methods for making and using such complexes |
WO2013039861A2 (en) | 2011-09-12 | 2013-03-21 | modeRNA Therapeutics | Engineered nucleic acids and methods of use thereof |
AU2013243949A1 (en) | 2012-04-02 | 2014-10-30 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of biologics and proteins associated with human disease |
CA2868398A1 (en) | 2012-04-02 | 2013-10-10 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
WO2013158773A2 (en) * | 2012-04-17 | 2013-10-24 | The Research Institute At Nationwide Children's Hospital | Rnase 7 antimicrobial peptides |
MY151307A (en) * | 2012-06-18 | 2014-05-05 | Univ Malaya | Peptides having antimicrobial activity |
GB201401877D0 (en) | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
EP3067608A1 (de) * | 2015-03-10 | 2016-09-14 | Abu Dhabi Polymers Co. Ltd (Borouge) LLC. | Exzentrisches Polyolefinrohr |
CA3004790A1 (en) | 2015-11-10 | 2017-05-18 | Visterra, Inc. | Lipopolysaccharide binding antibody-antimicrobial peptide conjugates and uses thereof |
AU2018209940A1 (en) | 2017-01-18 | 2019-07-11 | Visterra, Inc. | Antibody molecule-drug conjugates and uses thereof |
US11021529B2 (en) | 2017-03-03 | 2021-06-01 | Massachusetts Institute Of Technology | Antimicrobial constructs and uses thereof |
US10934943B2 (en) | 2017-04-27 | 2021-03-02 | General Electric Company | Compressor apparatus with bleed slot and supplemental flange |
US11179516B2 (en) | 2017-06-22 | 2021-11-23 | Baxter International Inc. | Systems and methods for incorporating patient pressure into medical fluid delivery |
EP4126064A1 (de) | 2020-04-03 | 2023-02-08 | Visterra, Inc. | Antikörpermolekül-wirkstoff-konjugate und verwendungen davon |
CU20200086A7 (es) * | 2020-11-19 | 2022-06-06 | Centro De Investig Y Desarrollo De Medicamentos Cidem | Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206154A (en) | 1985-01-28 | 1993-04-27 | Xoma Corporation | Method of producing cecropins by microbiological techniques |
US5166321A (en) | 1985-01-28 | 1992-11-24 | International Genetic Engineering, Inc. | Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria |
US5028530A (en) | 1985-01-28 | 1991-07-02 | Xoma Corporation | AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
US4810777A (en) | 1987-03-04 | 1989-03-07 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial compounds |
US4822608A (en) | 1987-09-14 | 1989-04-18 | Vespa Laboratories, Inc. | Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof |
IL90356A0 (en) | 1988-05-27 | 1989-12-15 | Magainin Sciences Inc | Amphiphilic peptides and pharmaceutical compositions containing them |
SE8802939D0 (sv) | 1988-08-19 | 1988-08-19 | Kabigen Ab | A method for the production and isolation of a fusion protein in eukaryotic cells |
WO1990004408A1 (en) | 1988-10-21 | 1990-05-03 | Magainin Sciences, Inc. | Composition and treatment with biologically active peptides and certain anions |
WO1990004407A1 (en) | 1988-10-21 | 1990-05-03 | Magainin Sciences, Inc. | Cpf peptide compositions and uses |
US5217956A (en) | 1988-10-21 | 1993-06-08 | The Children's Hospital Of Philadelphia | Composition and treatment with biologically active peptides and certain anions |
CA2007913A1 (en) | 1989-01-30 | 1990-07-30 | Michael Zasloff | Composition and treatment with peptide combinations |
US5254535A (en) | 1989-04-17 | 1993-10-19 | The Children's Hospital Of Pennsylvania | Composition and treatment with biologically active peptides and antibiotic |
FR2646777B1 (fr) | 1989-05-12 | 1993-09-03 | Bio Serae Lab | Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications |
US5073542A (en) | 1989-06-07 | 1991-12-17 | Magainin Sciences Inc. | CPF peptide compositions and their use in inhibiting growth of target cells or a virus |
US5045531A (en) | 1989-12-18 | 1991-09-03 | Magainin Sciences Inc. | Wound treatment employing biologically active ion channel forming peptides and proteins |
EP0514464A4 (en) | 1990-02-08 | 1993-04-28 | Magainin Sciences, Inc. | Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
US5227469A (en) | 1990-02-14 | 1993-07-13 | Genentech, Inc. | Platelet aggregation inhibitors from the leech |
JPH05509295A (ja) | 1990-04-23 | 1993-12-22 | マゲイニン サイエンセズ インコーポレーテッド | 生物学的に活性なペプチドおよび毒性陽イオンを有する組成物およびこれらを使用する治療法 |
JPH05507077A (ja) | 1990-04-27 | 1993-10-14 | マゲイニン サイエンセズ インコーポレーテッド | 生物活性ペプチドおよび駆虫剤もしくは抗真菌剤を使う組成物および治療法 |
WO1991017760A1 (en) | 1990-05-14 | 1991-11-28 | Magainin Sciences Inc. | Composition of and treatment with biologically active peptides having d-amino acid residues |
US5208220A (en) | 1990-06-27 | 1993-05-04 | Magainin Pharmaceuticals, Inc. | Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase |
US5202420A (en) | 1990-10-25 | 1993-04-13 | The Children's Hospital Of Philadelphia | Tracheal antimicrobial peptides, dna sequences and methods for the production and use thereof |
US5235038A (en) | 1991-01-22 | 1993-08-10 | Torry Pines Institute For Molecular Studies | Deletion and substitution analogues of melittin peptide |
EP0579763A4 (de) | 1991-04-08 | 1994-12-21 | Magainin Pharma | Neuartige peptidzusammensetzungen und ihre verwendungen. |
AU667479B2 (en) | 1991-06-12 | 1996-03-28 | Magainin Pharmaceuticals, Inc. | Treating the oral cavity with ion-channel forming peptides |
EP0590044A4 (en) | 1991-06-12 | 1996-06-12 | Magainin Pharma | Composition and treatment with biologically active peptides having c-terminal substitutions |
US5547939A (en) * | 1991-06-14 | 1996-08-20 | The Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
US5324716A (en) * | 1991-06-14 | 1994-06-28 | Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
EP0667871A1 (de) | 1991-09-13 | 1995-08-23 | Magainin Pharmaceuticals Inc. | Biologisch aktive amphiphile peptidzusammensetzungen und ihre verwendungen |
CA2125494A1 (en) | 1991-12-09 | 1993-06-24 | Barry Berkowitz | Composition and treatment with biologically active peptides and chelating agents |
CA2137087A1 (en) | 1992-06-01 | 1993-12-09 | U. Prasad Kari | Biologically active peptides having n-terminal substitutions |
JPH08501213A (ja) * | 1992-08-21 | 1996-02-13 | ザ ユニバーシティー オブ ブリティッシュ コロンビア | カチオン性ペプチド及びその製造方法 |
CA2106720C (en) | 1992-09-23 | 1997-12-16 | Charles L. Deschenes | Needle for use as part of a plastic fastener dispensing tool |
US5635594A (en) * | 1994-03-11 | 1997-06-03 | University Of California, Los Angeles | Gallinacins - antibiotic peptides |
US5877274A (en) * | 1995-06-02 | 1999-03-02 | University Of British Columbia | Antimicrobial cationic peptides |
-
1996
- 1996-08-23 WO PCT/IB1996/000996 patent/WO1997008199A2/en active Application Filing
- 1996-08-23 AU AU69407/96A patent/AU6940796A/en not_active Abandoned
- 1996-08-23 JP JP51006897A patent/JP3860838B2/ja not_active Expired - Fee Related
- 1996-08-23 US US08/702,054 patent/US6191254B1/en not_active Expired - Fee Related
- 1996-08-23 EP EP96930303A patent/EP0846128B1/de not_active Expired - Lifetime
- 1996-08-23 DE DE69637731T patent/DE69637731D1/de not_active Expired - Lifetime
- 1996-08-23 ES ES96930303T patent/ES2316154T3/es not_active Expired - Lifetime
- 1996-08-23 CA CA002230160A patent/CA2230160A1/en not_active Abandoned
- 1996-08-23 AT AT96930303T patent/ATE412668T1/de not_active IP Right Cessation
-
1998
- 1998-12-10 HK HK98113071.8A patent/HK1011867A1/xx not_active IP Right Cessation
-
2003
- 2003-03-28 US US10/403,104 patent/US7390873B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HK1011867A1 (en) | 1999-07-23 |
WO1997008199A3 (en) | 1997-09-12 |
AU6940796A (en) | 1997-03-19 |
JPH11511971A (ja) | 1999-10-19 |
US20040019181A1 (en) | 2004-01-29 |
US6191254B1 (en) | 2001-02-20 |
WO1997008199A2 (en) | 1997-03-06 |
CA2230160A1 (en) | 1997-03-06 |
JP3860838B2 (ja) | 2006-12-20 |
ATE412668T1 (de) | 2008-11-15 |
ES2316154T3 (es) | 2009-04-01 |
EP0846128A2 (de) | 1998-06-10 |
EP0846128B1 (de) | 2008-10-29 |
US7390873B2 (en) | 2008-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69637731D1 (de) | Antimikrobielle kationische peptide und methoden zu ihrer identifizierung | |
TW281675B (de) | ||
DE69739035D1 (de) | Zusammensetzungen und Methoden zur Behandlung von Infektionen unter Verwendung von Indolicidinanalogen | |
ATE176241T1 (de) | 3-amino-2-oxo-piperidinessigsäurederivate, die eine argininnachahmende verbindung, mit enzyminhibitorischen wirkung enthalten | |
AU5249898A (en) | N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds | |
DE69030100D1 (de) | Peptidderivat, verfahren zu dessen herstellung, sowie dieses enthaltende pharmazeutische zusammensetzung | |
AU1383297A (en) | Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity | |
ES2192620T3 (es) | Polipeptido receptor de il-13. | |
PT866691E (pt) | Administracao sublingual e bucal de selegilina | |
DE69530404D1 (de) | Analogen des keratinozytenwachstumfaktors | |
CA2094347A1 (en) | A method of producing a factor viii preparation | |
BR9609847A (pt) | Derivados de N-(4-Benzila-substituída)-2-aminolactam | |
IL122606A (en) | (S)-hydroxa-nitrile-lyase | |
AU579593B2 (en) | Novel peptides which are active on the central nervous system and have an action on the cholinergic system | |
PT635025E (pt) | Processo para preparar proteinas modificadas | |
BR9609337A (pt) | Preparação de derivado de biciclohexano | |
CA2136103A1 (en) | Antibiotic cryptdin peptides and methods of their use | |
DE69633234D1 (de) | Reinigung von dalbeheptide-antibiotika mittels isoelektrofokussierung | |
GR3021408T3 (en) | Cloning of a new member of the fibroblast growth factor (fgf) receptor family | |
CA2033730A1 (en) | Heparin-binding growth factor | |
DK0382268T3 (da) | Aminocarboxylsyrederivater | |
FR2654430B1 (fr) | Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes. | |
ES2088000T3 (es) | Procedimiento para la obtencion de (2s,3s)-3-etilasparaginatos de dialquilo n-protegidos. | |
AU2001277717A1 (en) | Novel proteins and dnas thereof | |
NZ331432A (en) | Process for the preparation of N-methyl-D-phenylalanyl-N-[1-[3-[(aminoiminomethyl)amino]propyl]-3,3 -difluoro-2-oxohexyl]-l-prolinamide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |